Search research articles
Contact Us
Filters
Showing results (1-10 of 83) with videos related to
Page
of 9
Sort By:
Kidney International Reports
|
March 14, 2024
Complement and Podocytopathies: Do We Have a New Biomarker?
Miquel Blasco, Andrew S Bomback
Nefrologia
|
August 6, 2018
Role of sustained low efficiency dialysis in the intensive care unit
Alícia Molina-Andújar, Miquel Blasco, Esteban Poch
Disaster Medicine and Public Health Preparedness
|
September 9, 2020
Evaluation of COVID-19 Surveillance Strategy in Ecuador
Ricardo Cañizares Fuentes, Rubén Aroca, Miquel Blasco Carlos
Clinical Kidney Journal
|
June 13, 2015
Rescue therapy with eculizumab in a transplant recipient with atypical haemolytic-uraemic syndrome
Carlos E Durán, Miquel Blasco, Francisco Maduell, et al.
Frontiers in Medicine
|
May 13, 2022
Complement Mediated Endothelial Damage in Thrombotic Microangiopathies
Miquel Blasco, Elena Guillén-Olmos, Maribel Diaz-Ricart, et al.
Medicina Clinica
|
December 1, 2014
[Atypical hemolytic uremic syndrome]
Miquel Blasco Pelicano, Santiago Rodríguez de Córdoba, Josep M Campistol Plana
Seminars in Nephrology
|
July 13, 2025
Should Genetic Testing be Indicated and Implemented for Chronic Kidney Disease of Unknown Cause?
Julia Jefferis, Amali Mallawaarachchi, Nine Knoers, et al.
Molecular Immunology
|
July 11, 2019
ANCA associated vasculitis: The journey to complement-targeted therapies
Luis F Quintana, Andreas Kronbichler, Miquel Blasco, et al.
Journal of Nephrology
|
March 22, 2025
Kidney cyst infection management among European nephrologists: a survey
Charles Ronsin, Nora Schwotzer, Johann Morelle, et al.
Clinical Nephrology
|
October 1, 2013
Clinical management of calcific uremic arteriolopathy before and after therapeutic inclusion of bisphosphonates
José-Vicente Torregrosa, Ana Sánchez-Escuredo, Xoana Barros, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 83) with videos related to
Sort By:
Page
of 9
Kidney International Reports
|
March 14, 2024
Complement and Podocytopathies: Do We Have a New Biomarker?
Miquel Blasco, Andrew S Bomback
Nefrologia
|
August 6, 2018
Role of sustained low efficiency dialysis in the intensive care unit
Alícia Molina-Andújar, Miquel Blasco, Esteban Poch
Disaster Medicine and Public Health Preparedness
|
September 9, 2020
Evaluation of COVID-19 Surveillance Strategy in Ecuador
Ricardo Cañizares Fuentes, Rubén Aroca, Miquel Blasco Carlos
Clinical Kidney Journal
|
June 13, 2015
Rescue therapy with eculizumab in a transplant recipient with atypical haemolytic-uraemic syndrome
Carlos E Durán, Miquel Blasco, Francisco Maduell, et al.
Frontiers in Medicine
|
May 13, 2022
Complement Mediated Endothelial Damage in Thrombotic Microangiopathies
Miquel Blasco, Elena Guillén-Olmos, Maribel Diaz-Ricart, et al.
Medicina Clinica
|
December 1, 2014
[Atypical hemolytic uremic syndrome]
Miquel Blasco Pelicano, Santiago Rodríguez de Córdoba, Josep M Campistol Plana
Seminars in Nephrology
|
July 13, 2025
Should Genetic Testing be Indicated and Implemented for Chronic Kidney Disease of Unknown Cause?
Julia Jefferis, Amali Mallawaarachchi, Nine Knoers, et al.
Molecular Immunology
|
July 11, 2019
ANCA associated vasculitis: The journey to complement-targeted therapies
Luis F Quintana, Andreas Kronbichler, Miquel Blasco, et al.
Journal of Nephrology
|
March 22, 2025
Kidney cyst infection management among European nephrologists: a survey
Charles Ronsin, Nora Schwotzer, Johann Morelle, et al.
Clinical Nephrology
|
October 1, 2013
Clinical management of calcific uremic arteriolopathy before and after therapeutic inclusion of bisphosphonates
José-Vicente Torregrosa, Ana Sánchez-Escuredo, Xoana Barros, et al.
Page
of 9